Tissue distribution and clearance of intravenously administered titanium dioxide (TiO2) nanoparticles

Nanotoxicology

Volumn 8, Issue 2, 2014, Pages 132-141

  Shinohara, Naohide ^a   Danno, Nobuko ^b   Ichinose, Takayuki ^c   Sasaki, Takeshi ^a   Fukui, Hiroko ^a   Honda, Kazumasa ^a   Gamo, Masashi ^a  

^a NATIONAL INSTITUTE OF ADVANCED INDUSTRIAL SCIENCE AND TECHNOLOGY AIST   (Japan)

^b Kamakura Techno science Inc   (Japan)

^c TORAY RESEARCH CENTER INC   (Japan)

Author keywords

Clearance; Distribution; Excretion; Nanomaterial; Toxicokinetics

Indexed keywords

DRINKING WATER; METAL NANOPARTICLE; TITANIUM DIOXIDE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; AQUEOUS SOLUTION; ARTICLE; BODY BURDEN; CLEARANCE; CONTROLLED STUDY; FECES ANALYSIS; HEART; KIDNEY; LIMIT OF DETECTION; LIVER; LUNG; MALE; MASS SPECTROMETRY; MEDIASTINUM LYMPH NODE; NONHUMAN; ORGAN DISTRIBUTION; PARTICLE SIZE; PRIORITY JOURNAL; RAT; SPLEEN; TISSUE DISTRIBUTION; URINALYSIS;

ANIMAL FEED; ANIMALS; DRINKING WATER; FECES; INJECTIONS, INTRAVENOUS; KIDNEY; LUNG; MALE; MASS SPECTROMETRY; METAL NANOPARTICLES; RATS; RATS, INBRED F344; TISSUE DISTRIBUTION; TITANIUM;

EID: 84890347545     PISSN: 17435390     EISSN: 17435404     Source Type: Journal    
DOI: 10.3109/17435390.2012.763001     Document Type: Article

References (30)

1. Bermudez E, Mangum JB, Wong BA, Asgharian B, Hext PM, Warheit DB, et al. 2004. Pulmonary responses of mice, rats, and hamsters to subchronic inhalation of ultrafine titanium dioxide particles. Toxicol Sci 77(2):347-357
2. Borghoff S, Parkinson H, Leavens T. 2010. Physiologically based pharmacokinetic rat model for methyl tertiary-butyl ether; comparison of selected dose metrics following various MTBE exposure scenarios used for toxicity and carcinogenicity evaluation. Toxicology 275:79-91
3. Cho MJ, Cho WS, Choi M, Kim SJ, Han BS, Kim SH, et al. 2009. The impact of size on tissue distribution and elimination by single intravenous injection of silica nanoparticles. Toxicol Lett 189(3) 177-183
4. Diehl KH, Hull R, Morton D, Pfister R, Rabemampianina Y, Smith D, et al. 2001. A good practice guide to the administration of substances and removal of blood, including routes and volumes. J Appl Toxicol 21(1):15-23
5. Donaldson K, Stone V, Clouter A, Renwick L, MacNee W. 2001. Ultrafine particles. Occup Environ Med 58(3):211-216
6. Fabian E, Landsiedel R, Ma-Hock L, Wiench K, Wohlleben W, Ravenzwaay B. 2008. Tissue distribution and toxicity of intravenously administered titanium dioxide nanoparticles in rats. Arch Toxicol 82:151-157
7. Fuji Chimera Research Institute, Inc. 2009. Metallic Oxide 10. Ultrafine Particle Titanium Dioxide, Metallic Oxide 12. Titanium Dioxide for Photocatalyst, III. Market Compilation by Commodity Item, Current State and Future Outlook of the Ultrafine Particle Market in 2009. [Japanese]
8. Kreyling WG, Wenk A, Behnke M. 2010. Quantitative biokinetic analysis of radioactively labelled, inhaled Titanium dioxide Nanoparticles in a ratmodel. Federal Environment Agency (Umweltbundesamt). http:// www.umweltdaten.de/ publikationen/fpdf-l/4022.pdf
9. Lankveld DPK, Oomen AG, Krystek P, Neigh A, Troost A, Noorlander CW, et al. 2010. The kinetics of the tissue distribution of silver nanoparticles of different sizes. Biomaterials 31:8350-8361
10. Lesniak A, Campbell A, Monopoli MP, Lynch I, Salvati A, Dawson KA. 2010. Serum heat inactivation affects protein corona composition and nanoparticle uptake. Biomaterials 31:9511-9518
11. Lu Y, Rieth S, Lohitnavy M, Dennison J, El-Masri H, Barton HA, et al. 2008. Application of PBPK modeling in support of the derivation of toxicity reference value for 1,1,1-Trichloroethane. Regul Toxicol Pharm 50:249-260
12. Lynch I, Dawson KA. 2008. Protein-nanoparticle interactions. Nanotoday 3(1-2):40-47
13. Ma-Hock L, Burkhardt S, Strauss V, Gamer A, Wiench K, van Ravenzwaay B, et al. 2009. Development of a short-Term inhalation test in the rat using nano-Titanium dioxide as a model substance. Inhalation Toxicology 21(2):102-118
14. Nakata K. 1994. Proliferation of alveolar macrophages. In: Takishima Teditor. Basic and Clinical Aspects of Pulumonary Fibrosis. CRC Press, Boca Raton. pp133-146
15. Naito M. 2001. A basic information of macrophage 3. Distribution and form of macrophage. In: Takahashi K, Naito M, Takeya M, editors. Macrophage. Bunkodo Co. Ltd Tokyo, Japan. pp 13-31
16. Oberdörster G, Oberdörster E, Oberdörster J. 2005. Nanotoxicology: An emerging discipline evolving from studies of ultrafine particles. Environ Health Persp 113(7):823-839
17. Pastino GM, Asgharian B, Roberts K, Medinsky MA, Bond JA. 1997. A comparison of physiologically based pharmacokinetic model predictions and experimental data for inhaled ethanol in male and female B6C3F1 mice, F344 rats, and humans. Toxicol Appl Pharmacol 145:147-157
18. Peyret T, Poulin P, Krishnan K. 2010. A unified algorithm for predicting partition coefficients for PBPK modeling of drugs and environmental chemicals. Toxicol Appl Pharmacol 249:197-207
19. Rehn B, Seiler F, Rehn S, Bruch J, Maier M. 2003. Investigation on the inflammatory and genotoxic lung effects of two types of titanium dioxide: Untreated and surface treated. Toxicol Appl Pharmacol 189:84-95
20. Sager TM, Kommineni C, Castranova V. 2008. Pulmonary response to intratracheal instillation of ultrafine versus fine titanium dioxide: Role of Particle surface area. Part Fibre Toxicol 5:17
21. Sarin H. 2010. Physiologic upper limits of pore size of different blood capillary types and another perspective on the dual pore theory of microvascular permeability. J Angiogenes Res 2:14
22. Shinohara N, Nakazato T, Tamura M, Endoh S, Fukui H, Morimoto Y, et al. 2010. Clearance kinetics of fullerene C60 nanoparticles from rat lungs after intratracheal C60 instillation and inhalation C60 exposure. Toxicol Sci 118(2):564-573
23. Sugibayashi K, Todo H, Kimura E. 2008. Safety evaluation of titanium dioxide nanoparticles by their absorption and elimination profiles. J Toxicol Sci 33(3):293-298
24. The Chemical Daily. 2010. Titanium dioxide: Recovering demand due to the world market expansion (12 Sep. 2010
25. van Ravenzwaay B, Landsiedel R, Fabian E, Burkhardt S, Strauss V, Ma-Hock L. 2009. Comparing fate and effects of three particles of different surface properties: Nano-TiO2, pigmentary TiO2 and quartz. Toxicol Lett 186:152-159
26. Wang JX, Chen C, Liu YY, Jiao F, Li W, Lao F, et al. 2008. Potential neurological lesion after nasal instillation of TiO2 nanoparticles in the anatase and rutile crystal phases. Toxicol Lett 183(1-3):72-80
27. Wang JX, Zhou GQ, Chen CY, Yu HW, Wang TC, Ma YM, et al. 2007. Acute toxicity and biodistribution of different sized titanium dioxide particles in mice after oral administration. Toxicol Lett 168:176-185
28. Warheit DB, Webb TR, Reed KL, Frerichs S, Sayes CM. 2007. Pulmonary toxicity study in rats with three forms of ultrafine-TiO2 particles: Differential responses to surface properties. Toxicology 230:90-104
29. Xie G, Wang C, Sun J, Zhong G. 2011. Tissue distribution and excretion of intravenously administered titanium dioxide nanoparticles. Toxicol Lett 205(1):55-61
30. Zhang L, Bai R, Li B, Ge C, Du J, Liu Y, et al. 2011. Rutile TiO2 particles exert size and surface coating dependent retention and lesions on the murine brain. Toxicol Lett 207(1):73-81